GENB
Generate Biomedicines, Inc.
Key Financials
Revenue
$13.5M
N/A
Operating Income
$-135726000
N/A
Net Income
$-128701000
N/A
EPS (Diluted)
$-1.41
N/A
Total Assets
$561.7M
N/A
Cash & Equivalents
$135.4M
N/A
Shareholders' Equity
$456.0M
N/A
Total Liabilities
$105.6M
N/A
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/6/2026 | View on SEC |
| 8-K | 8/6/2026 | View on SEC |
| SCHEDULE 13G | 5/15/2026 | View on SEC |
| SCHEDULE 13G | 5/15/2026 | View on SEC |
| 10-Q | 5/7/2026 | View on SEC |
| 8-K | 5/7/2026 | View on SEC |
| 3 | 3/12/2026 | View on SEC |
| 4 | 3/6/2026 | View on SEC |
| 4 | 3/2/2026 | View on SEC |
| 4 | 3/2/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GENB |
| Company Name | Generate Biomedicines, Inc. |
| CIK | 2100782 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 888-469-0055 |